BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Emerald Health Pharmaceuticals To Treat Life-Threatening Diseases With Novel Synthetic Cannabinoid-Derived Molecules

  Emerald Health Pharmaceuticals Inc. (EHP) today announced its mission to discover, develop and commercialize novel synthetic cannabinoid-derivative drug candidates to treat life-threatening diseases.

  September 15, 2017

   · 

  7 min read
• Boehringer Ingelheim Receives Positive CHMP Opinion For Adalimumab Biosimilar CYLTEZO

  September 15, 2017

   · 

  3 min read
• Samsung Bioepis First To Receive Positive CHMP Opinion On A Trastuzumab Biosimilar With ONTRUZANT

  September 15, 2017

   · 

  1 min read
• Genetown

  H3 Biomedicine To Present New Data On H3B-6527, An FGFR4 Inhibitor, At The 2017 International Liver Cancer Association Annual Meeting

  September 15, 2017

   · 

  4 min read
• Biotech Bay

  Aradigm To Host KOL Call On Infection Management In Non-Cystic Fibrosis Bronchiectasis Patients

  September 15, 2017

   · 

  5 min read
• FDA

  CSL Behring Announces FDA Approval Of Privigen [Immune Globulin Intravenous (Human), 10% Liquid] For The Treatment Of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) In Adults

  September 15, 2017

   · 

  8 min read
• Mazor Robotics Announces Closing Of The Third Tranche Equity Investment

  September 15, 2017

   · 

  2 min read
• TissueTech Awarded Four Patents For Proprietary Technology To Use Placental Tissue For Regenerative Medicine

  September 15, 2017

   · 

  3 min read
• Drug Development

  Biohaven And Alzheimer’s Disease Cooperative Study (ADCS) Announce Phase II Clinical Trial Collaboration Evaluating Glutamate Modulating Agent Trigriluzole In Patients With Mild-To-Moderate Alzheimer’s Disease

  September 15, 2017

   · 

  6 min read
• Policy

  Janssen Biotech Submits Supplemental New Drug Application To U.S. FDA For ZYTIGA (Abiraterone Acetate) To Treat Men With Earlier Stages Of Metastatic Prostate Cancer

  September 15, 2017

   · 

  13 min read